MHRA publishes the outcome of ‘MLX 364’.
The Medicines and Healthcare products Regulatory
Agency (MHRA) has, for a number of months, been undertaking a public
consultation on the use of Nicotine Containing Products (NCP).
consultation process’s findings had potential for significant impact
upon our ability to continue to service your
requirements for recreational e-nicotine products. Today the MHRA has
published the outcome of a public consultation exercise ‘MLX 364’. The
findings are very positive. The report illustrates the significant
influence you the users have been able to provide to the Agency’s
We at NUCIG believe that the MHRA should be
commended for its judgement and obvious valued consideration it has
taken from a significant wide base of stakeholders. It recognises, as we
at NUCIG recognise, that our new industry requires regulation to
support the safest and highest quality products for the user. However,
it balances the need for clear unambiguous evidence to be available to
define and implement the necessary regulation. The MHRA proposes a
further 18 month of consideration and evaluation before it believes it
will be able to report conclusive direction in Spring 2013.
NUCIG has and will continue to work with the
MHRA to assist as we can in defining the appropriate regimes our
business should be working under to support best the needs of our
industry’s user community. In the mean time we will continue to take a
leading position in driving innovation and quality and keep you our
customers at the centre of our business motivations.
The MHRA report can be read in full following this link.
MLX 364, MHRA, ecigs, e-cigs,
electric cigarette, electronic cigarette, smoke free, ecig, e-cig,
electric cigarettes, electronic cigarettes, smoke free ,ecigs, ecigarette, electric